$296 Million is the total value of Krensavage Asset Management, LLC's 13 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 7.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Buy | UNITED THERAPEUTICS CORP | $53,545,000 | -13.9% | 491,693 | +1.1% | 18.08% | +13.2% |
| MCK | Buy | MCKESSON CORP | $45,015,000 | -12.6% | 407,490 | +5.0% | 15.20% | +14.8% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $37,882,000 | -13.3% | 534,825 | +4.6% | 12.79% | +13.9% |
| AMGN | Sell | AMGEN INC | $34,721,000 | -21.2% | 178,358 | -16.1% | 11.72% | +3.5% |
| GILD | Sell | GILEAD SCIENCES INC | $33,195,000 | -20.4% | 530,699 | -1.7% | 11.21% | +4.6% |
| MRK | Sell | MERCK & CO. INC. | $32,865,000 | -9.3% | 430,117 | -15.8% | 11.10% | +19.1% |
| SHPG | Sell | SHIRE PLC | $24,393,000 | -6.9% | 140,157 | -3.1% | 8.24% | +22.3% |
| RTIX | Sell | RTI SURGICAL INC | $16,442,000 | -18.1% | 4,443,771 | -0.4% | 5.55% | +7.6% |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $6,336,000 | -9.2% | 200,967 | +0.5% | 2.14% | +19.3% |
| IVC | Buy | INVACARE CORP | $5,719,000 | -63.4% | 1,329,899 | +23.7% | 1.93% | -52.0% |
| OFIX | Sell | ORTHOFIX MEDICAL INC | $2,974,000 | -83.4% | 56,664 | -81.7% | 1.00% | -78.2% |
| AVNS | Sell | AVANOS MEDICAL INC | $2,890,000 | -43.2% | 64,515 | -13.1% | 0.98% | -25.3% |
| DRAD | Sell | DIGIRAD CORP | $188,000 | -62.3% | 329,870 | -0.8% | 0.06% | -50.8% |
| Exit | SIEMENS HEALTHINEERS AG | $0 | – | -396,406 | -100.0% | -4.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2019-02-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.